At a glance
ClinicalIndex Comparison RecordN/ACompleted· 692 enrolled
Drug / intervention
voriconazole IVdrug
Likely dose
voriconazole IV 6 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV
In Brief
An observational study evaluating voriconazole IV for Serious Fungal Infections. Completed, enrolled 692 participants.
Detailed Summary
This is non-interventional study of voriconazole IV formulation in clinical use, which was mandated by the Korean government agency following the approval of Vfend in the Republic of Korea.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSerious Fungal Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2006
Primary CompletionOct 2009
First PostedFeb 2010
TodayJul 2026
First PostedFeb 23, 2010
Enrollment StartMar 1, 2006
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 16.4 years ago
Interventions
voriconazole IVdrug
6 mg/kg iv q 12 hours (loading) then maintenance